Regulatory T cells: recommendations to simplify the nomenclature

  title={Regulatory T cells: recommendations to simplify the nomenclature},
  author={Abul K. Abbas and Christophe Benoist and Jeffrey A. Bluestone and Daniel J. Campbell and Sankar Kumar Ghosh and Shohei Hori and Shuiping Jiang and Vijay K. Kuchroo and Diane Mathis and Maria Grazia Roncarolo and Alexander Y. Rudensky and Shimon Sakaguchi and Ethan M. Shevach and Dario A A Vignali and Steven F. Ziegler},
  journal={Nature Immunology},
c o rr e s p o n d e n c e npg © 2013 Nature America, Inc. All rights reserved. Regulatory T cells: recommendations to simplify the nomenclature To the Editor: Regulatory T cells (T reg cells) have attracted much interest from both basic and clinical immunologists. Although questions remain about their fundamental biology and their clinical potential has yet to be fully realized, considerable advances have been made in the under- standing of the differentiation, homeostasis and function of T… 
Minimum Information about T Regulatory Cells: A Step toward Reproducibility and Standardization
It is hoped that MITREG will be a useful tool facilitating standardized reporting on the manufacturing of Tregs, either for research purposes or for clinical application, and might also be an important step toward more standardized and reproducible testing of the T Regs preparations in clinical applications.
T-cell biology, tolerance, and regulation
  • A. Cava
  • Biology
    Lahita's Systemic Lupus Erythematosus
  • 2021
Regulatory T cells : molecular and clinical aspects
It is found that muscle invasive tumors have a lower FOXP3+ fraction at the invasive front compared to non-invasive counterparts, and changes in the cellular immune response dependent on if the patients have received neo-adjuvant chemotherapy or not are observed.
Expanding Diversity and Common Goal of Regulatory T and B Cells. I: Origin, Phenotype, Mechanisms
Phenotype diversity, confirmed or hypothetical developmental pathways, multiple mechanisms of action, and role of epigenetic changes in these processes are the subject of this review.
Peripheral and Thymic Foxp3+ Regulatory T Cells in Search of Origin, Distinction, and Function
The validity and controversy regarding Helios, Lap/Garp and Neuropilin-1 as markers of thymic Tregs are addressed and updated information on distinguishing features of these two subsets and their critical roles in maternal-fetal tolerance and transplantation is discussed.
Regulatory T cells: the future of autoimmune disease treatment
This work presents recent advances in the research on the biology and clinical applications of Tregs in the treatment of autoimmune diseases and suggests that growing knowledge about Treg biology together with the latest biotechnology tools may give an opportunity for personalized therapies in these conditions.
Regulatory T Cells – Molecular and Clinical Aspects THESIS FOR DOCTORAL DEGREE ( Ph . D . )
The epigenetic regulation of FOXP3 expression is addressed, and it is demonstrated that the committed Treg population has an almost completely demethylated FoxP3 promoter region, whereas conventional non-regulatory CD4+ T lymphocytes are semi-methylated in this region.
Phenotypical characterization of regulatory T cells in humans and rodents
The most common markers utilized for Treg typification by flow cytometry such as CD25, forkhead box protein 3 (FoxP3) and CD127 are revised and the expression of other molecules important for the phenotypical characterization of Treg cells are determined.
An important part is assigned to T regs in the pathogenesis of autoimmune rheumatic diseases, RA in particular, as the decrease in the level and functional activity of T Regs is likely to underlie the development of uncontrolled chronic inflammation leading to multiple organ damages.